Skip to main content
Caplight Logo









Zenflow

Zenflow

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.zenflow.com/

Last Round

Series D

Oct 5, 2026

Total Funding Raised

$141.6M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Zenflow is a medical device company that develops minimally invasive treatments for urinary obstruction caused by benign prostatic hyperplasia (BPH).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

benign prostatic hyperplasiaBPHminimally invasive urologyurology medical deviceprostatic urethral implanturology implantoffice-based urologyurology surgeryurology procedureurology techmedical device manufacturerurology hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zenflow Comparables

Compare Zenflow with similar companies based on industry and business-model similarity.

Zenflow comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ProVerum Medical
88%
Butterfly Medical
87%
Prodeon Medical
87%

Zenflow Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DOct 5, 2026
Series CNov 18, 2024
Series BJun 2, 2021
DebtNov 27, 2018
Series AFeb 7, 2018
Seed
Dec 31, 2017

Key People

Founding team and executive leadership

Shreya Mehta

Chief Executive Officer

Executive Team

Ronald Jabba

Chief Operating Officer

Executive Team

Zenflow Investors

Notable investors and investment history

Zenflow investors
InvestorRounds
StartXSeed
NIH RADxSeries A
F-Prime CapitalSeries C, Series B, Series A
Astia AngelsSeries B
ClavystBioSeries D
Cloudstone CapitalSeries B
Medical Technology Venture PartnersSeries C, Series B, Series D, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 5, 2026

    $52M round led by Cook Medical.

  • Sep 12, 2026

    Monthly visitors increased 32% MoM.

Recent news

Latest coverage and updates

  • receives_financingOct 5, 2026

    Zenflow secures $52M Series D financing in California on Oct 5th '26

  • launchesSep 8, 2026

    Zenflow launched Zenflow Spring Implant and Delivery System on Sep 8th '26.

Zenflow Filings

Explore SEC and related filing metadata, where available.

Zenflow filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Zenflow's valuation, stock price, and market status.

Is Zenflow a public or private company?

Zenflow is a private company.

What is the current stock price of Zenflow?

Zenflow is a private company, so its shares have no public market price. Caplight tracks Zenflow's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Zenflow worth (valuation)?

Valuation information for Zenflow is not publicly available.

Can I buy Zenflow stock?

Zenflow shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Zenflow's last funding round?

Zenflow's most recent funding round was Series D on October 5, 2026.

Who are the main investors in Zenflow?

Key investors in Zenflow include F-Prime Capital, Medical Technology Venture Partners, Invus Opportunities, F-Prime Capital.

Will Zenflow IPO soon?

No public IPO plans have been announced for Zenflow.

How can I track Zenflow secondary market activity?

Caplight tracks bids, offers, and trades in Zenflow's shares on secondary markets.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range28
Year Founded2014
Last FundingOct 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?